IMPORTANCE Policy makers and practitioners need rigorous evaluations of state-based Medicaid enhanced prenatal care programs that provide home visiting to guide improvements and inform future investments. Effects on adverse birth outcomes are of particular interest.
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Previous evaluations of state-sponsored EPC programs have shown mixed effects for improvement in birth outcomes. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Most studies have methodologic limitations, including failing to account for program selection bias or the dosage of services. 28 Randomized controlled trials of targeted home visiting programs, with few exceptions, 29, 30 have typically not found improved birth outcomes. [31] [32] [33] [34] [35] Regardless, trials
are not feasible for EPC programs with Medicaid populationbased eligibility serving women with varying levels of risk, need for services, and readiness to engage in services. Policy makers and practitioners need rigorous evaluations of state-based EPC programs to guide program improvements and inform investment decisions. Furthermore, eligibility for new home visiting funding, authorized under the Patient Protection and Affordable Care Act, will require testing program models using randomized controlled trial or quasiexperimental designs to be considered an evidence-based program. 3, 36 To address the need for rigorous testing of prenatal home visiting, we conducted a quasi-experimental evaluation of the effectiveness of Michigan's EPC program, the Maternal Infant Health Program (MIHP), accounting for program timing and dosage, and used a propensity score-matching method to address selection bias. The study was designed to meet federal Patient Protection and Affordable Care Act and similar Michigan legislative home visiting evaluation requirements for consideration as an evidence-based program.
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The MIHP is a population-based home visiting program available to all Medicaid-eligible pregnant women and for infants until age 1 year. 37 Services are delivered by registered nurses and licensed social workers. The MIHP promotes healthy pregnancies and positive birth outcomes through comprehensive risk screening, care coordination, and evidence-based interventions embedded in standardized program protocols (eg, smoking cessation and motivational interviewing). The study was undertaken after extensive investment in program improvement and standardization efforts. We previously identified positive MIHP effects in improving maternal and infant health care use, including prenatal care. 38 The objective of this study was to examine the overall effects of MIHP on birth weight and gestational age and investigate program effects for black women who are at greater risk than other women for adverse birth outcomes. We build on the work of Slaughter and colleagues, 28 who studied Iowa's prenatal case management program (93% non-Hispanic white), by matching a diverse group of MIHP participants with nonparticipants. We hypothesized that women in MIHP would have better birth outcomes compared with matched nonparticipants, and differences would be most pronounced for pregnant women who enrolled and were screened in the first or second trimester and received at least 3 additional prenatal MIHP contacts.
Methods

Study Design and Population
This study used a quasi-experimental design to compare the birth outcomes of women in MIHP with a matched comparison group from among the Medicaid-insured women who did not participate in MIHP. 
Variables
Outcomes Birth outcomes, defined as binary indicators, included (1) low birth weight (LBW), defined as less than 2500 g reported on the birth certificate; (2) preterm birth, described as delivery before 37 completed weeks' gestation based on the last menstrual period self-reported on the birth certificate; (3) very low birth weight (VLBW), established as less than 1500 g reported on the birth certificate; and (4) very preterm birth, defined as delivery before 32 completed weeks' gestation.
MIHP Participation
An MIHP participation indicator was coded "yes" if at least 1 maternal claim with MIHP Current Procedural Terminology or Healthcare Common Procedure Coding System codes submitted by an MIHP provider was present during pregnancy or an MIHP prenatal screener record was identified; otherwise, it was coded "no." When estimating the effects of MIHP participation, we excluded from the preterm birth and very preterm birth analyses women who enrolled in MIHP after the outcome threshold, 37 and 32 weeks' gestation, respectively. To capture the effects of MIHP enrollment timing, a second MIHP participation indicator was coded 1 if women enrolled in MIHP in the first or second trimester and 0 if not participating in the program. This is consistent with a trial study that found greater improvements in birth outcomes for women enrolled in the first 2 trimesters. 29 We excluded women who enrolled in MIHP in the third trimester since exploratory analyses indicated progressively decreased preterm birth rates for those recruited closer to full term. This was likely the result of inherently being further along in the pregnancy and more likely to carry the pregnancy to term and not an MIHP effect. A third MIHP participation dosage indicator was coded 1 if women enrolled in MIHP and were screened in the first or second trimester and had at least 3 additional MIHP contacts during pregnancy and 0 if not participating in MIHP, consistent with other studies that use or show a dosage effect.
28,39
Matching Maternal Baseline Characteristics
Maternal age, marital status, race and ethnicity, county of residence, prenatal smoking, first-time pregnancy, and rapid repeat pregnancy within 18 months and 2 socioeconomic status measures were included. The first binary indicator identified pregnant women at or below the 33% federal poverty level (FPL) based on their participation in the LowIncome Family Program and receipt of cash assistance. The second binary indicator distinguished between women who had Medicaid before pregnancy (income up to 63% FPL if older than 19 years, which describes most participants in our study, and up to 150% if 19 years or younger) and higher-income women who became Medicaid eligible after confirming the pregnancy, with income up to 185% FPL regardless of age. 5 Three binary indicators for maternal chronic conditions were also included, coded 1 if related claims during pregnancy were present based on diagnostics and procedure codes and 0 otherwise. To minimize the possibility of measurement error, including potential disease onset after MIHP program enrollment during pregnancy, we considered the most prevalent conditions defined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes: asthma (ICD-9-CM codes 491-493), diabetes mellitus (ICD-9-CM code 250), and hypertension (ICD-9-CM codes 401-405).
Statistical Analysis
Women enrolled in MIHP were compared with all women not enrolled in the program ( Table 1 ). The probability of MIHP participation (the propensity score) was then estimated for the entire cohort as a function of all baseline characteristics using logistic regression. 40, 41 Estimations were performed separately for black women and for women of other races and ethnicities. A one-to-one matched control group from among the nonparticipants was selected. After random sorting of the propensity scores, the nearest-neighbor matching method without replacement on a Mahalanobis distance with a caliper of 0.2 SD, within the same race (black vs others), was used. 42 Bivariate conditional logistic regression analyses were performed to assess baseline equivalence between the MIHP participants and the matched comparison group ( Table 2) . Propensity score models were adjusted, including considering interactions, higher-order terms, and multiple matches, to ensure maximum balance on baseline covariates. 40, 43 Using the individual county of residence (vs state regions) as a baseline covariate minimized the number of duplicate propensity scores. The MIHP enrolled 18 798 pregnant clients who had a singleton birth in 2010. Using the first MIHP definition, the reported propensity score analysis retained more than 85% of the MIHP clients in the analyses matched with nonparticipants. The other 15% were excluded due to missing relevant baseline data or because a match was not found within the caliper ( Table 2 , columns 1-2). The matching process yielded more than a 99% propensity score overlap between the MIHP group and the matched comparison group. The aforementioned analyses were separately estimated for each of the 3 MIHP definitions, including propensity score estimations and matching. Table 2 reports the baseline equivalence using all 3 MIHP definitions. Table 3 presents the prevalence of outcomes in the matched samples of interest. There were 0.04% observations with missing data in the birth weight and 5% with missing data in the completed weeks' gestation, which were omitted from the analyses. To test the hypothesis of MIHP having favorable effects on birth outcomes, we compared MIHP participants, applying the 3 alternative MIHP definitions, with matched comparison groups using conditional logistic regressions adjusted for the county of residence. Odds ratios (ORs) and 95% CIs were reported ( Table 4) . We performed analyses with women of all races and separately for black women and women of other races.
Unobserved variables simultaneously affecting the treatment assignment and the outcomes may generate a "hidden bias" to which matching estimators may not be robust. 44 The bounding approach proposed by Rosenbaum determines how strongly an unmeasured variable must influence the selection into MIHP to invalidate our birth outcome results. 44, 45 We calculated how much larger than 1 (OR = 1 is the assumption of no hidden bias) would the odds of MIHP exposure need to be for our findings to lose statistical significance if there was a negative unobserved MIHP selection (Table 5) . SAS, version 9.1.3 (SAS Institute), and Stata, version 11 (StataCorp LP), were used to perform the analyses.
Results
There were 60 653 Medicaid-insured singleton births in Michigan during 2010, with both mother and newborn insured by Medicaid at birth; approximately 30% (n = 18 762) of the mothers participated in the MIHP during pregnancy. There were significant differences among all the baseline characteristics between MIHP participants and the women who did not participate in the program ( 10.7%), and were more likely to have asthma, diabetes mellitus, or hypertension. Fewer women in the non-MIHP group were married (21.9% vs 33.2%), were on Medicaid before pregnancy (53.2% vs 65.6%), and reported smoking during pregnancy (28.4% vs 30.6%). Table 2 shows that after selecting a matched comparison group using the propensity score method, we established baseline equivalence on all the characteristics included in our analyses for each of the 3 MIHP definitions (except individual county of residence; data not shown).
In general, the prevalence of LBW, VLBW, preterm births, and very preterm births was lower among the women in MIHP compared with the matched control groups (Table 3) (Table 4, I ). When considering women who enrolled in MIHP by the end of the second trimester, thus excluding lateenrolled women who were also less likely to deliver early, significant program-control differences were limited to VLBW (OR, 0.76; 95% CI, 0.59-0.97) and very preterm births (0.68; 0.54-0.85) for black participants (Table 4, II) .
When comparing MIHP participants who enrolled in the program by the second trimester and who were screened for prenatal risk with at least 3 additional MIHP contacts with matched nonparticipants, we found significant risk reduction among black women and women of other races (Table 4, Unobserved characteristics would have to cause differences in the odds of treatment assignment between the MIHP group and the control group with an OR as high as 1.7 to invalidate the favorable MIHP effects on VLBW and an OR of 1.92 for very preterm births among black women enrolled and screened in the first 2 trimesters and with more than 3 additional contacts, indicating robustness of the MIHP effects (Table 5 ).
Discussion
For black women who enrolled in the program by the end of the second trimester, participation decreased the odds of having an extreme adverse birth outcome, specifically VLBW and very preterm births. Enrolling in the program in the first 2 trimesters and receiving screening and at least 3 additional faceto-face prenatal contacts decreased the odds of having adverse birth outcomes-LBW, VLBW, preterm births, and very preterm births-for women of all races, with the MIHP effects on VLBW and very preterm births for black women less sensitive to potential unobserved confounders.
Our results are consistent with several randomized controlled trial evaluations that found participation in prenatal home visiting programs had positive effects on birth weight and stronger effects for women enrolled in the first trimester and for black women.
29,30 These studies found no program effect on reducing prematurity. Cooper and colleagues 46 used propensity score matching in an urban population and found that participation in a federal Healthy Start home visiting program significantly reduced the odds of LBW (OR, 0.28) and prematurity (OR, 0.25). However, the study relied on a small sample size (84 in the intervention group), limited matching characteristics, and did not account for timing and dosage of services. Our study methods limit comparison with many studies of Medicaid state-sponsored EPC programs. Most state program evaluations were observational and had limitations, including selection bias and lack of timing and dosage of services. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Slaughter and colleagues 28 addressed some of these limitations by using propensity score-adjusted regression analysis to evaluate the Iowa prenatal care management program. The study found that receiving a moderate (1-3 contacts) to high (>3 contacts) amount of prenatal care management contacts decreased the odds of having a LBW or preterm birth in non-Hispanic white women. Our MIHP evaluation had several strengths. First, the quasiexperimental propensity score-matching design was rigorous, accounting for potential bias and dosage of services. Second, our study population was a statewide birth cohort of Medicaid-insured infants and their mothers. Since the Michigan population is racially heterogeneous, including rural and large metropolitan areas, our results are generalizable. Third, we included analyses of the robustness of our findings to the possibility of hidden bias due to unobserved selection factors. Finally, the realization that late-enrolled women were more likely to carry the pregnancy past the very preterm and preterm births, as well as the resulting exclusions, avoided the overestimation of program effects.
Several limitations are noted. We used an analysis that balanced on selection factors expected to influence participation in MIHP, yet, as with other observational studies, our matching was limited to observable characteristics documented in our data. Other selection factors potentially unmeasured may affect our findings. For example, women who enroll in MIHP may have higher psychosocial resources and greater readiness to engage in services. Another notable unavailable characteristic was maternal education, not present in the limited version of the birth certificate data available through the Michigan Department of Community Health warehouse (our data source). For selected adverse birth outcomes, however, the extent of bias induced by potential unobserved selection factors needs to be large to invalidate our favorable MIHP findings. Another potential limitation is the approximate 15% observations lost in the matching process. While not uncommon, it could bias our results if the lost observations were not a random sample. 47 Women receiving our proposed dosage of contacts could be a selected subgroup with longer pregnancies. However, more than 96% of the women with this MIHP dosage receive at least 3 additional visits before 37 completed pregnancy weeks, close to 85% by 32 weeks, and close to 70% by 28 weeks' gestation, limiting the potential overestimation of the MIHP effects. 
